GRACE THERAPEUTICS INC (GRCE) Stock Cash Flow
NASDAQ:GRCE - Nasdaq - US00439U1043 - Common Stock - Currency: USD
| 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.85M | -42.43M | -9.82M | -19.68M | -25.51M | |||
| Depreciation Amortization | 11.00K | 120.00K | 0.00 | 920.00K | 2.32M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.28M | 180.00K | -2.79M | -5.95M | -3.22M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.79M | 26.21M | -4.63M | 10.38M | 3.46M | |||
| OPERATING CASH FLOW | -12.33M | -15.91M | -17.23M | -14.32M | -22.95M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -22.00K | -20.00K | 0.00 | -70.00K | -320.00K | |||
| Other Investing Activity | 126.00K | 13.17M | -3.52M | -9.79M | 8.46M | |||
| INVESTING CASH FLOW | 104.00K | 13.15M | -3.52M | -9.86M | 8.14M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | -1.56M | |||
| Stock Issued/Repurchased | 7.36M | 300.00K | 0.00 | 59.63M | 14.73M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -140.00K | 10.00K | |||
| FINANCING CASH FLOW | 7.36M | 300.00K | 0.00 | 59.49M | 13.18M | |||
| Exchange Rate Effect | 0.00 | -10.00K | 150.00K | 1.39M | -1.00M | |||
| CHANGE IN CASH | -4.87M | -2.47M | -20.60M | 36.70M | -2.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.33M | -15.91M | -17.23M | -14.32M | -22.95M | |||
| Capital Expenditure | -22.00K | -20.00K | 0.00 | -70.00K | -320.00K | |||
| FREE CASH FLOW | -12.36M | -15.93M | -17.23M | -14.39M | -23.27M | |||
All data in USD